Arvee Laboratories (India) Saurin Ajitbhai Gandhi resigns
Arvee Laboratories (India) (ARVEE) said Saurin Ajitbhai Gandhi has resigned. The company is valued at about ₹236 crore.
What happened
In a filing with the NSE on 3 November 2026 at 08:07 PM, Arvee Laboratories (India) (ARVEE) said that Saurin Ajitbhai Gandhi has resigned.
From the filing: "Arvee Laboratories (India) Limited has informed the Exchange regarding Resignation of Mr Saurin Ajitbhai Gandhi as Non- Executive Director of the company w.e.f."
Company snapshot
Arvee Laboratories (India) is a micro-cap company, with a market value of about ₹236 crore.
The stock last traded at ₹213.8, against a 52-week range of ₹129.1–₹290.8 (26.5% below the high).
Before this filing the shares had moved −6.7% over the month and +35.2% over three months. Average daily turnover over the last 20 sessions was about ₹0.16 crore.
Promoters held 73.50% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 7 | 0.2 | 0.15 |
| Q2 FY26 | 3 | 0 | 0.01 |
| Q3 FY26 | 10 | 1.8 | 1.66 |
| Q4 FY26 | 11 | 0.5 | 0.47 |
| Q1 FY27 | 17 | 1.7 | 1.54 |
What history shows
This is not the company's first management change disclosure: BCEIE has 1 earlier filing of this kind on record since May 2026.
Market-wide, 4,237 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
Market reaction so far
Since the filing, the stock has risen 1.7%, from ₹210.2 before the disclosure to ₹213.8 (last close).
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 3 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
- Arvee Laboratories (India) Limited (ARVEE.NS) Gains 3.88% to ₹177.9 as Buyers Reclaim Upper Range - Call Wall
- Arvee Laboratories (India) Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
- Arvee Laboratories (ARVEE.NS) Rallies 5% to ₹206.71, Nearing Resistance at ₹217.05 - Fibonacci Arc
- Arvee Laboratories (ARVEE.NS) Q2 2026 Earnings: EPS of ₹2.29 Holds Positive Even as Revenue Slips 18.21% YoY - Annual Financial Report
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.